相关实验视频

Updated: Jun 24, 2025

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

几乎完美的精确的在目标上编辑人类造血干细胞和原始细胞

Fanny-Mei Cloarec-Ung¹, Jamie Beaulieu¹, Arunan Suthananthan¹

¹Institut de Recherche en Immunologie et en Cancérologie, Université de Montréal, Montéal, Canada.

|June 3, 2024

概括

现在可以在人类造血干细胞和原始细胞 (HSPC) 中实现超过90%的精确基因编辑. 优化的CRISPR/Cas9输送和捐赠者设计将治疗应用的毒性和非目标效应降至最低.

科学领域:

分子生物学分子生物学
基因治疗基因治疗
血液学血液学血液学

背景情况:

精确的基因编辑在造血干细胞和原生细胞 (HSPCs) 中对于治疗遗传疾病和疾病建模至关重要.
当前的CRISPR/Cas9系统在初级HSPC中实现高精确的编辑效率方面存在局限性.

研究的目的:

优化基因编辑协议,使其在人类初级HSPC中具有高效率和精度.
评估HSPC优化基因编辑在不同原始基因水平的安全性和有效性.

主要方法:

优化导向RNA输送,捐赠者设计,并添加DNA-PK抑制剂AZD7648.8.
在捐赠者DNA中嵌入了破坏间距的静态突变和破坏PAM的突变.
评估编辑效率,毒性,非目标效应以及对HSPC层次和功能的影响.

主要成果:

在初级带血HSPC中达到超过90%的平均精确编辑效率,毒性最小.
没有观察到非目标编辑;编辑分布在原始层次结构中是一致的.
在功能分析中,基因编辑并没有显著改变HSPC等级或血统输出.

结论:

优化的基因编辑协议可以直接在人类HSPC中实现近乎完美的效率.
这一进步为开发单一性疾病的治愈疗法和改善疾病建模提供了显著的潜力.
通过混合捐赠者类型来调整编辑和双相性的能力为各种应用提供了灵活性.

关键词:

克里斯普尔是什么意思?克里斯普尔是什么意思?基因组编辑基因组编辑血液形成血液形成造血干细胞是造血干细胞的组成部分.人类人类人类人类人类人类人类这种白血病是白血病.再生医学是一种再生医学.干细胞是一种干细胞.干细胞是干细胞的组成部分.

更多相关视频

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

相关概念视频

Multipotency of Hematopoietic Stem Cells

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...